Title: Kenneth Gregory Moore: Innovator in Fungal Lipase Applications
Introduction
Kenneth Gregory Moore is an inventor based in Charlottesville, VA (US). He has made significant contributions to the field of biochemistry, particularly in the development of methods to reduce serum levels of triacylglycerides in humans. His innovative approach utilizes fungal lipase formulations to address health concerns related to high serum triacylglyceride levels.
Latest Patents
Kenneth Gregory Moore holds a notable patent titled "Methods And Compositions To Reduce Serum Levels Of Triacylglycerides In Human Beings Using A Fungal Lipase." This invention focuses on the oral administration of an effective amount of a fungal lipase formulation to human subjects with borderline-high or high serum levels of triacylglycerides. The goal is to reduce these levels over a sufficient time period, showcasing the potential of fungal lipase in therapeutic applications.
Career Highlights
Throughout his career, Kenneth has worked with various companies, including Bio-Cat, Inc. and his own venture, Moore, Kenneth Gregory. His work has been instrumental in advancing the understanding and application of fungal lipases in medical treatments.
Collaborations
Kenneth has collaborated with professionals such as Christopher Schuler and Edward Schuler. These partnerships have likely contributed to the development and refinement of his innovative approaches in the field.
Conclusion
Kenneth Gregory Moore is a dedicated inventor whose work in fungal lipase applications has the potential to significantly impact health outcomes related to triacylglyceride levels. His contributions to biochemistry and collaboration with other professionals highlight his commitment to innovation in this important area.